LTFU Study of Subjects With Cervical SCI Who Received AST-OPC1

Running, not enrolling

Conditions studied: Spinal Cord Injuries

In brief

This is a LTFU study for cervical SCI subjects that were administered AST-OPC1 cells in the main study AST-OPC1-01.

Key facts

Study ID

NCT05975424

Run by

Lineage Cell Therapeutics, Inc.

People needed

25

Starts

2018-06-13

Expected to finish

2033-01-14

Last updated by the study team

2024-08-21

Who can join

Age: 18 and older, up to 69. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects who received AST-OPC1 under Study AST-OPC1-01
• Reconfirmation of consent for long-term follow-up

You may not qualify if…

• Subjects who, for geographic or compliance reasons, are inappropriate candidates for participation in a long-term follow-up study in the opinion of the Investigator

Where it is running

• University of Southern California — Los Angeles, California, United States
• Stanford University — Palo Alto, California, United States
• Shepherd Center — Atlanta, Georgia, United States
• RUSH University Medical Center — Chicago, Illinois, United States
• Thomas Jefferson University — Philadelphia, Pennsylvania, United States
• Medical College of Wisconsin — Milwaukee, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.